Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2000
|
| gptkbp:ATCCode |
M05BA07
|
| gptkbp:CASNumber |
105462-24-6
|
| gptkbp:chemicalFormula |
C7H11NO7P2Na
|
| gptkbp:contraindication |
hypocalcemia
inability to stand or sit upright for 30 minutes |
| gptkbp:drugClass |
bisphosphonate
|
| gptkbp:genericName |
risedronate sodium
|
| gptkbp:halfLife |
1.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Actonel
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Sanofi
gptkb:Warner_Chilcott |
| gptkbp:mechanismOfAction |
inhibits osteoclast-mediated bone resorption
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
abdominal pain
dyspepsia musculoskeletal pain Esophageal cancer |
| gptkbp:usedFor |
gptkb:bone
gptkb:Paget's_disease_of_bone |
| gptkbp:bfsParent |
gptkb:risedronate
gptkb:Warner_Chilcott |
| gptkbp:bfsLayer |
7
|